Literature DB >> 26463061

Viewpoint: a proposal for a simple algorithm for managing oral anticoagulation and antiplatelet therapy in patients with non-valvular atrial fibrillation and coronary stents.

Ph Gabriel Steg1,2,3,4, Deepak L Bhatt5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26463061     DOI: 10.1177/2048872615610868

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


× No keyword cloud information.
  4 in total

1.  Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.

Authors:  Gilles Lemesle; Gregory Ducrocq; Yedid Elbez; Eric Van Belle; Shinya Goto; Christopher P Cannon; Christophe Bauters; Deepak L Bhatt; Philippe Gabriel Steg
Journal:  Clin Cardiol       Date:  2017-07-10       Impact factor: 2.882

Review 2.  Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare.

Authors:  Sean Esmonde; Divyesh Sharma; Aaron Peace
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

3.  Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.

Authors:  Lili Wei; Enyong Su; Weili Liu; Wenlu Xing; Xinyun Liu; You Zhang; Shan Wang; Qianqian Cheng; Datun Qi; Chuanyu Gao
Journal:  BMC Cardiovasc Disord       Date:  2020-07-06       Impact factor: 2.298

4.  Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.

Authors:  Christopher P Cannon; Savion Gropper; Deepak L Bhatt; Stephen G Ellis; Takeshi Kimura; Gregory Y H Lip; Ph Gabriel Steg; Jurriën M Ten Berg; Jenny Manassie; Jörg Kreuzer; Jon Blatchford; Joseph M Massaro; Martina Brueckmann; Ernesto Ferreiros Ripoll; Jonas Oldgren; Stefan H Hohnloser
Journal:  Clin Cardiol       Date:  2016-08-26       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.